financial statements 50. financial Policies for risk management anD tHeir oBJectives continueD liquidity risk less than two to more than one year five years five years total 2013 $m $m $m $m cash and cash equivalents 4 4 accounts receivable 2 2 interest bearing loans and borrowings 26 141 167 other payables 1 1 21 141 162 less than two to more than one year five years five years total 2012 $m $m $m $m cash and cash equivalents 6 6 interest-bearing loans and borrowings 35 99 63 197 29 99 63 191 the company believes that, given the groups forecast operating cash flow during 2013, it has the ability to satisfy its liability commitments.
51. staff costs Hikma Pharmaceuticals Plc currently has 10 employees 2012: 10 excluding executive Directors : total compensation paid to them amounted to $3 million 2012: $3 million of which salaries and wages compromise an amount of $2 million 2012: $2 million, the remaining balance of $1 million 2012: $1 million represents national insurance contributions, the cost of share-based payments and other benefits.
52. stock oPtions the details of the stock compensation scheme are provided in note 36. as at 31 December 2013, the total number of options granted toemployees of the company under the stock compensation scheme during the life of the scheme was 2,560,000 2012: 2,560,000 andthetotalamount of compensation expenses charged to profit or loss is $nil 2012: $nil.
53. long-term incentive Plan the details of the ltiP scheme are provided in note 36. as at 31 December 2013, the total number of awards granted to employees of the company under the ltiPs during the life of the plan was 1,521,000 shares 2012: 1,331,000 shares and the total amount of the compensation expenses charged to profit and loss is $1 million 2012: $2 million.
54. management incentive Plans the details of the miP scheme are provided in note 36. as at 31 December 2013, the total number of awards granted to employees of the company under the miP during the life of the plan was 10,000 shares 2012: 4,000 shares and the total amount of the compensation expenses charged to profit and loss is $nil 2012: $nil.
55. sHare caPital 2013 2012 issued and fully paid included in shareholders equity: $m $m 198,044,328 2012: 197,036,507 ordinary shares of 10p each 35 35 Details of the issue of share capital in the year are given in note 31.
